How hepatitis B is tested on Step 1

Most questions give a serology panel and ask for the patient's status. Others test virology, transmission, or associated diseases.

HBsAgAnti-HBsAnti-HBcHBeAgInterpretation
+βˆ’IgM+Acute infection, highly infectious
βˆ’βˆ’IgMβˆ’Window period (recovering acute infection)
βˆ’+IgGβˆ’Recovered, immune from natural infection
βˆ’+βˆ’βˆ’Immune from vaccination
+βˆ’IgG+ or βˆ’Chronic infection (HBeAg+ = high replication)

HBcAg itself is not detected in serum; only antibodies to it are measured.

Acute hepatitis B that resolves (typical pattern)Exposure1 mo2 mo3 mo4 mo6 mo1 yrHBsAgInfectionHBeAgReplicationAnti-HBc IgMAcute + windowAnti-HBsImmunity
Window period. After HBsAg disappears and before anti-HBs appears, anti-HBc IgM is the only positive marker. Timing varies between patients.

Virology and transmission

HBV is a DNA virus that uses reverse transcriptase.

  • Structure: enveloped hepadnavirus with partially double-stranded circular DNA; DNA polymerase with reverse transcriptase activity.
  • Transmission: blood, sexual contact, and perinatal (mother to child). It is far more infectious by needlestick than HCV or HIV.
  • Histology: "ground-glass" hepatocytes from accumulated HBsAg; liver damage is mainly from the cytotoxic T-cell response, not the virus itself.
  • Chronicity by age: about 90% of perinatal infections, 25–50% of infections at ages 1–5, and fewer than 5% of adult infections become chronic.
HDV coinfectionHBV and HDV acquired togetherAcute hepatitisUsually clears like acute HBVChronicity uncommonHDV superinfectionHDV infects a chronic HBV carrierSevere acute flareUsually becomes chronicFaster progression to cirrhosisvs
Hepatitis D is a defective RNA virus that uses HBsAg as its envelope. Preventing HBV prevents HDV.

Complications and extrahepatic disease

Chronic HBV causes liver and immune-complex disease.

CirrhosisFibrosis from chronic immune injuryHCCCan occur without cirrhosis (viral DNA integration);↑ AFPPolyarteritis nodosaImmune-complex vasculitis of medium arteriesGlomerular diseaseMembranous nephropathy, MPGNFulminant hepatitisRare acute liver failure
Chronic HBV complications. Surveillance for HCC is recommended in high-risk chronic carriers.

Prevention and treatment

Know the vaccine and the antiviral classes.

  • Vaccine: recombinant HBsAg (a subunit vaccine) β†’ anti-HBs only. Given to all infants starting at birth.
  • Infants of HBsAg-positive mothers: hepatitis B vaccine plus hepatitis B immune globulin (HBIG) within 12 hours of birth.
  • Chronic HBV drugs: nucleos(t)ide reverse transcriptase inhibitors such as tenofovir and entecavir (suppress replication); pegylated interferon-Ξ± in selected patients.
  • Needlestick from an HBsAg-positive source: unvaccinated people receive HBIG and the vaccine series.

Worked example

Read the panel step by step.

functions Worked example β€” the confusing panel

A 30-year-old had jaundice 3 months ago that has resolved. Labs: HBsAg negative, anti-HBs negative, anti-HBc IgM positive, HBeAg negative. What is her status?

  1. HBsAg negative: no detectable surface antigen now.
  2. Anti-HBs negative: no protective antibody yet.
  3. Anti-HBc IgM positive: recent acute infection.
  4. This combination is the window period between HBsAg clearance and anti-HBs appearance.

Answer. Window period of a resolving acute hepatitis B infection.